Soluble TRAIL levels in the conjunctival sac fluid [26] and in vitreous samples [28] have been reported to be significantly decreased in patients with diabetic retinopathy and to protect against diabetes [19]. Here, TNFSF10 is linked to diabetic retinopathy.